Skip to main content

FDA recall, , Moderate risk

Galt Medical Boston Scientific Enhance Transcarotid/Peripheral Access Kit

The Enhance Transcarotid/Peripheral Access Kit has black depth markings that may detach from the outer sheath.

What happened

Galt Medical Corporation, based in Garland, Texas, recalled the Boston Scientific Enhance Transcarotid/Peripheral Access Kit because black depth markings may detach from the outer sheath of the coaxial dilator introducer component. The recall began June 26, 2026, and was added to the FDA's Enforcement Report on August 7, 2026.

The affected product is the Boston Scientific Enhance Transcarotid/Peripheral Access Kit REF: SR-4F21G7D-MP (Kit-075-03) Sheath with Dilator, Stiffen Dilator, Nitinol Mandrel Wire w/ Radiopaque Tip [Au}, Needle, Extension Tube with Stopcock. Distribution was in Minnesota.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the UDI-DI and lot code listed under your product.

Incomplete list: 40 of 231 lot codes shown.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Boston Scientific Enhance Transcarotid/Peripheral Access Kit REF: SR-4F21G7D-MP (Kit-075-03) Sheath with Dilator , Stiffen Dilator, Nitinol Mandrel Wire w/ Radiopaque Tip [Au}, Needle, Extension Tube with Stopcock

    UDI-DI
    • 00841268107250
    Lot code
    • G22171212
    • G22201213
    • G22201214
    • G22201215
    • G22201216
    • G22201217
    • G22201218
    • G22234219
    • G22234220
    • G22262227
    • G22234221
    • G22234222
    • G22234223
    • G22262225
    • G22234224
    • G22262226
    • G22262228
    • G22262229
    • G22262230
    • G22292231
    • G22292232
    • G22292233
    • G22292234
    • G22292235
    • G22292236
    • G22292237
    • G22320238
    • G22320239
    • G22320240
    • G22320241
    • G22320242
    • G22320243
    • G22320244
    • G22354191
    • G22362192
    • G22362194
    • G22362195
    • R23083454
    • G23076104
    • G23076105

Recall details

Company began the recall
Sold in

US Nationwide distribution in the state of Minnesota.

Company
Galt Medical CorporationGarland, Texas
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99369
Recall number
Z-2917-2026
Quantity recalled
114,260 kits

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 25, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)